2003
DOI: 10.1111/j.1749-6632.2003.tb07265.x
|View full text |Cite
|
Sign up to set email alerts
|

Inhibition of the Na,K‐ATPase by the Antiarrhythmic Drug, Bretylium

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2004
2004
2009
2009

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(1 citation statement)
references
References 3 publications
0
1
0
Order By: Relevance
“…This finding may have implications for our understanding of the antiarrhythmic effect of adenosine when used clinically. The inhibition of Na + -K + pump prolongs action potential duration and myocardial refractoriness, which is involved in the mechanisms of two other widely used antiarrhythmic agents, bretylium and amiodarone [33,34] . Thus, it is tempting to speculate that the antiarrhythmic effects of adenosine are in part caused by Na + -K + pump inhibition.…”
Section: Discussionmentioning
confidence: 99%
“…This finding may have implications for our understanding of the antiarrhythmic effect of adenosine when used clinically. The inhibition of Na + -K + pump prolongs action potential duration and myocardial refractoriness, which is involved in the mechanisms of two other widely used antiarrhythmic agents, bretylium and amiodarone [33,34] . Thus, it is tempting to speculate that the antiarrhythmic effects of adenosine are in part caused by Na + -K + pump inhibition.…”
Section: Discussionmentioning
confidence: 99%